NPA's Fly-in Day 2026: A Battle for Health Freedom and Innovation
The Natural Products Association (NPA) is gearing up for its annual Fly-in Day in 2026, a pivotal event that showcases the organization's unwavering commitment to safeguarding consumer access to safe, natural products. With a rich history dating back to 1936, NPA has become a formidable watchdog, advocating for regulatory and legislative initiatives that ensure the safety and compliance of dietary supplements while preventing government overreach.
Protecting Consumers and Innovation
At the heart of NPA's agenda lies a fierce battle against the Mandatory Product Listing bill, a proposal that would burden supplement companies with registration requirements, including product details and allergen statements. Kyle Turk, NPA's vice president of government affairs, emphasizes the organization's stance: "The mission has remained remarkably consistent over nine decades: protect consumers, support responsible businesses, and preserve the future of the natural products industry."
NPA argues that this bill would create legal hurdles, lawsuits, and compliance costs, particularly harming smaller businesses and stifling innovation. They advocate for increased FDA enforcement and targeted action against illegal actors, rather than overburdening compliant businesses under the existing regulatory framework.
A key concern is the interpretation of Section 201(ff)(3)(B) of the DSHEA, known as the "drug preclusion" clause. NPA believes the FDA has expanded its authority beyond Congress's original intent, using this clause to remove ingredients from the market based on pharmaceutical research. This interpretation, they argue, creates market uncertainty and discourages innovation, putting consumer choice and wellness at risk.
The case of NMN (nicotinamide mononucleotide) exemplifies this issue. The FDA's decision to no longer consider NMN a dietary supplement due to prior drug investigation sparked NPA's legal and advocacy efforts. Through lawsuits, citizen petitions, and lobbying, NPA secured a victory when the FDA reinstated NMN's new dietary ingredient status, highlighting the importance of protecting innovation in the supplement industry.
Expanding Access and Ensuring Uniformity
NPA's agenda also includes expanding access to dietary supplements through Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). By updating IRS rules and providing access to a wider range of wellness products, NPA aims to encourage preventive care and reduce long-term healthcare costs.
Additionally, NPA is rallying against state-level initiatives that restrict supplement sales to minors or impose warning labels. The Dietary Supplement Regulatory Uniformity Act, introduced by Congressman Nick Langworthy, seeks to establish the FDA as the sole regulator, preventing conflicting state requirements. NPA's CEO, Dan Fabricant, emphasizes the importance of consumer access and the need to avoid costly state-specific regulations that override federal authority.
Conclusion: A Call for Common Sense Regulation
As NPA's Fly-in Day 2026 unfolds, the organization's efforts underscore a deeper call for a balanced and sensible approach to regulation. By protecting consumer access, supporting innovation, and ensuring uniformity, NPA strives to create a thriving natural products industry that benefits both businesses and consumers. This battle for health freedom and innovation is a testament to NPA's dedication to a healthier, more informed future.
